Sleep apnoea and cancer: The new challenge

European Respiratory Journal

Volumn 43, Issue 6, 2014, Pages 1567-1570

  Lévy, Patrick ^a,b,c   Godin Ribuot, Diane ^a,b   Pepin, Jean Louis ^a,b,c  

^a UNIV GRENOBLE ALPES   (France)

^b University Grenoble Alpes   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CAUSAL ATTRIBUTION; CORRELATIONAL STUDY; CUTANEOUS MELANOMA; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; HUMAN; INTERMITTENT HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SLEEP DISORDERED BREATHING; SLEEP PATTERN; TUMOR GROWTH; COMPLICATION; FEMALE; MALE; MELANOMA; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; SKIN TUMOR;

FEMALE; HUMANS; MALE; MELANOMA; PERCUTANEOUS CORONARY INTERVENTION; SKIN NEOPLASMS; SLEEP APNEA SYNDROMES;

EID: 84901847527     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00065714     Document Type: Editorial

References (44)

1. Strohl KP, Brown DB, Collop N, et al. An official American Thoracic Society clinical practice guideline: sleep apnea, sleepiness, and driving risk in noncommercial drivers. An update of a 1994 statement. Am J Respir Crit Care Med 2013; 187: 1259-1266.
2. Parati G, Lombardi C, Hedner J, et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013; 41: 523-538.
3. Lev'y P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 2009; 34: 243-260.
4. Pépin JL, Tamisier R, Lev'y P. Obstructive sleep apnoea and metabolic syndrome: put CPAP efficacy in a more realistic perspective. Thorax 2012; 67: 1025-1027.
5. Sivam S, Phillips CL, Trenell MI, et al. Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea. Eur Respir J 2012; 40: 913-918.
6. Campos-Rodriguez F, Martinez-Garcia MA, Martinez M, et al. Association between obstructive sleep apnea and cancer incidence in a large multicenter spanish cohort. Am J Respir Crit Care Med 2013; 187: 99-105.
7. Nieto FJ, Peppard PE, Young T, et al. Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 2012; 186: 190-194.
8. Almendros I, Montserrat JM, Ramirez J, et al. Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea. Eur Respir J 2012; 39: 215-217.
9. Nanduri J, Yuan G, Kumar GK, et al. Transcriptional responses to intermittent hypoxia. Respir Physiol Neurobiol 2008; 164: 277-281.
10. Almendros I, Wang Y, Becker L, et al. Intermittent hypoxia-induced changes in tumor-associated macrophages and tumor malignancy in a mouse model of sleep apnea. Am J Respir Crit Care Med 2014; 189: 593-601.
11. Almendros I, Montserrat JM, Torres M, et al. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea. Sleep Med 2012; 13: 1254-1260.
12. Almendros I, Montserrat JM, Torres M, et al. Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea. Respir Physiol Neurobiol 2013; 186: 303-307.
13. Hakim F, Wang Y, Zhang SX, et al. Fragmented sleep accelerates tumor growth and progression through recruitment of tumor-associated macrophages and TLR4 signaling. Cancer Res 2014; 74: 1329-1337.
14. Martínez-García M-Á, Martorell-Calatayud A, Nagore E, et al. Association between sleep disordered breathing and aggressiveness markers of malignant cutaneous melanoma. Eur Respir J 2014; 43: 1661-1668.
15. Orgaz JL, Sanz-Moreno V. Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res 2013; 26: 39-57.
16. Eggermont AMM, Spatz A, Robert C. Cutaneous melanoma. Lancet 2014; 383: 816-827.
17. Hodis E, Watson IR, Kryukov GV, et al. A landscape of driver mutations in melanoma. Cell 2012; 150: 251-263.
18. Mahabeleshwar GH, Byzova TV. Angiogenesis in melanoma. Semin Oncol 2007; 34: 555-565. (Pubitemid 350236307)
19. Wouters A, Pauwels B, Lardon F, et al. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist 2007; 12: 690-712. (Pubitemid 47036204)
20. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003; 195: 1-16. (Pubitemid 36603331)
21. Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor 1. Physiology 2009; 24: 97-106.
22. Hong SS, Lee H, Kim KW. HIF-1a : a valid therapeutic target for tumor therapy. Cancer Res Treat 2004; 36: 343-353.
23. Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nature Rev Cancer 2008; 8: 425-437. (Pubitemid 351744964)
24. Toffoli S, Michiels C. Intermittent hypoxia is a key regulator of cancer cell and endothelial cell interplay in tumours. FEBS J 2008; 275: 2991-3002. (Pubitemid 351743577)
25. Belaidi E, Beguin PC, Levy P, et al. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol 2008; 294: H901-H908. (Pubitemid 351253302)
26. Belaidi E, Joyeux-Faure M, Ribuot C, et al. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009; 53: 1309-1317.
27. Yuan G, Nanduri J, Bhasker CR, et al. Ca2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 2005; 280: 4321-4328. (Pubitemid 40288600)
28. +signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 2008; 217: 674-685.
29. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med Rev 2003; 7: 35-51. (Pubitemid 36188305)
30. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, et al. Reactive oxygen species contribute to sleep apneainduced hypertension in rats. Am J Physiol Heart Circ Physiol 2007; 293: H2971-H2976. (Pubitemid 350106521)
31. Dopp JM, Philippi NR, Marcus NJ, et al. Xanthine oxidase inhibition attenuates endothelial dysfunction caused by chronic intermittent hypoxia in rats. Respiration 2011; 82: 458-467.
32. Norton CE, Jernigan NL, Kanagy NL, et al. Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species. J Appl Physiol 2011; 111: 980-988.
33. Peng YJ, Nanduri J, Zhang X, et al. Endothelin-1 mediates attenuated carotid baroreceptor activity by intermittent hypoxia. J Appl Physiol 2012; 112: 187-196.
34. Ramond A, Godin-Ribuot D, Ribuot C, et al. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam Clin Pharmacol 2013; 27: 252-261.
35. Kaczmarek E, Bakker JP, Clarke DN, et al. Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One 2013; 8: e70559.
36. Lavie L, Kraiczi H, Hefetz A, et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 2002; 165: 1624-1628. (Pubitemid 34693942)
37. Gozal D, Lipton AJ, Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002; 25: 59-65. (Pubitemid 34072660)
38. Schulz R, Hummel C, Heinemann S, et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70. (Pubitemid 34053359)
39. Kalaria RN, Spoors L, Laude EA, et al. Hypoxia of sleep apnoea: cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neurobiol 2004; 140: 53-62. (Pubitemid 38510379)
40. da Rosa DP, Forgiarini LF, Baronio D, et al. Simulating sleep apnea by exposure to intermittent hypoxia induces inflammation in the lung and liver. Mediators Inflamm 2012; 2012: 879419.
41. Gu CJ, Li M, Li QY, et al. Chronic intermittent hypoxia increases beta cell mass and activates the mammalian target of rapamycin/hypoxia inducible factor 1/vascular endothelial growth factor a pathway in mice pancreatic islet. Chin Med J 2013; 126: 2368-2373.
42. Lukyanova LD, Sukoyan GV, Kirova YI. Role of proinflammatory factors, nitric oxide, and some parameters of lipid metabolism in the development of immediate adaptation to hypoxia and HIF-1a accumulation. Bull Exp Biol Med 2013; 154: 597-601.
43. Nikolaou V, Stratigos AJ. Emerging trends in the epidemiology of melanoma. Br J Dermatol 2014; 170: 11-19.
44. Peppard PE, Nieto FJ. Here come the sleep apnea-cancer studies. Sleep 2013; 36: 1409-1411.